TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15225 · Oct 15

#mdx#bilateral_teleoperation#force_feedback#genesis#gravity_compensation#humanoid_robot#imitation_learning#machine_learning#moveit2#mujoco#open_source#openarm#python#reinforcement_learning#robot#robot_arm#robotics#ros2#teleoperation OpenArm is a special robot arm that helps with physical AI research. It has 7 degrees of freedom, which means it can move like a human arm. This makes it good for tasks that involve touching or moving things safely around people. The robot is open-source, meaning anyone can build, modify, and use it. This is helpful because it makes advanced robotics available to more people, like researchers and students, without costing too much. A complete system with two arms costs about $6,500, which is much cheaper than similar robots. https://github.com/enactic/openarm

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment